20
Participants
Start Date
December 31, 2009
Primary Completion Date
December 31, 2014
Study Completion Date
June 30, 2016
Injection of stem cells at time of coronary artery bypass grafting
Following completion of the distal coronary artery bypasses, autologous CD133+ stem cells,or placebo solution containing plasma and indistinguishable will be injected in the myocardium. A total of 2.0 ml with 10-15 injections will be injected.
Centre de recherche du CHUM (CRCHUM), Montreal
Collaborators (1)
Miltenyi Biotec, Inc.
INDUSTRY
Centre de Recherche du Centre Hospitalier de l'Université de Montréal
OTHER
Maisonneuve-Rosemont Hospital
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER